Skip to main content
Top
Published in: Abdominal Radiology 11/2016

01-11-2016

Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes

Authors: Gevork N. Mnatzakanian, Atul B. Shinagare, V. Anik Sahni, Michelle S. Hirsch, Stuart G. Silverman

Published in: Abdominal Radiology | Issue 11/2016

Login to get access

Abstract

Purpose

Clear cell tubulopapillary renal cell carcinoma (CCTPRCC) is a recently described, low-grade subtype of renal cancer. We determined if imaging features could be used to distinguish early-stage CCTPRCC from stage-matched clear cell RCC (ccRCC) and papillary RCC (pRCC).

Methods

This IRB-approved retrospective study included 54 stage T1a patients with pathologically confirmed CCTPRCC (n = 18), ccRCC (n = 18), and pRCC (n = 18). CT (n = 48) and MRI (n = 27) exams were reviewed and imaging features compared. Continuous variables were evaluated using ANOVA and Tukey’s multiple comparison tests. Categorical variables were compared using Chi-square test or Fisher’s exact test.

Results

Compared to pRCC, CCTPRCC had a lower mean attenuation value on unenhanced CT (p < 0.017), was more often hyperintense on T2-weighted images (p < 0.0001), showed an ill-defined margin (p = 0.003), and demonstrated nonenhancing areas (p = 0.0003). The presence of all three of these statistically significant features [hypoattenuation (unenhanced attenuation ≤25 HU), ill-defined margin, nonenhancing areas] yielded an area under the receiver operator curve (ROC) of 0.92 (95% CI 0.83–0.99) for differentiating CCTPRCC from pRCC. There were no significant differences in the imaging features of CCTPRCC and ccRCC.

Conclusions

Early-stage clear cell tubulopapillary renal cell carcinoma can be distinguished from papillary RCC based on low attenuation on unenhanced CT, high intensity on T2-weighted images, an ill-defined margin, and presence of nonenhancing areas, but cannot be distinguished from clear cell RCC.
Literature
1.
go back to reference Srigley JR, Delahunt B, Eble JN, et al. (2013) The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol 37(10):1469–1489CrossRefPubMed Srigley JR, Delahunt B, Eble JN, et al. (2013) The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol 37(10):1469–1489CrossRefPubMed
2.
go back to reference Aydin H, Chen L, Cheng L, et al. (2010) Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol 34(11):1608–1621PubMed Aydin H, Chen L, Cheng L, et al. (2010) Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol 34(11):1608–1621PubMed
3.
go back to reference Montironi R, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L (2013) Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma. Histol Histopathol 28(12):1555–1566PubMed Montironi R, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L (2013) Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma. Histol Histopathol 28(12):1555–1566PubMed
4.
go back to reference Zhou H, Zheng S, Truong LD, et al. (2014) Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. Hum Pathol 45:59–64CrossRefPubMed Zhou H, Zheng S, Truong LD, et al. (2014) Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. Hum Pathol 45:59–64CrossRefPubMed
5.
go back to reference Aron M, Chang E, Herrera L, et al. (2015) Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor. Am J Surg Pathol 39:873–888CrossRefPubMed Aron M, Chang E, Herrera L, et al. (2015) Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor. Am J Surg Pathol 39:873–888CrossRefPubMed
6.
go back to reference Deml KF, Schildhaus HU, Comperat E, et al. (2015) Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma. Am J Surg Pathol 39:889–901CrossRefPubMedPubMedCentral Deml KF, Schildhaus HU, Comperat E, et al. (2015) Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma. Am J Surg Pathol 39:889–901CrossRefPubMedPubMedCentral
7.
go back to reference Gobbo S, Eble JN, Grignon DJ, et al. (2008) Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 32(8):1239–1245CrossRefPubMed Gobbo S, Eble JN, Grignon DJ, et al. (2008) Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 32(8):1239–1245CrossRefPubMed
8.
go back to reference Adam J, Couturier J, Molinié V, Vieillefond A, Sibony M (2011) Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases. Histopathology 58(7):1064–1071CrossRefPubMed Adam J, Couturier J, Molinié V, Vieillefond A, Sibony M (2011) Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases. Histopathology 58(7):1064–1071CrossRefPubMed
9.
go back to reference Rohan SM, Xiao Y, Liang Y, et al. (2011) Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 24(9):1207–1220CrossRefPubMed Rohan SM, Xiao Y, Liang Y, et al. (2011) Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 24(9):1207–1220CrossRefPubMed
10.
go back to reference Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30(2):141–153CrossRefPubMed Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30(2):141–153CrossRefPubMed
12.
go back to reference Silverman SG, Israel GM, Trinh QD (2015) Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology 275(1):28–42CrossRefPubMed Silverman SG, Israel GM, Trinh QD (2015) Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology 275(1):28–42CrossRefPubMed
13.
go back to reference Egbert ND, Caoili EM, Cohan RH, et al. (2013) Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR 201(2):347–355CrossRefPubMed Egbert ND, Caoili EM, Cohan RH, et al. (2013) Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR 201(2):347–355CrossRefPubMed
14.
go back to reference Silverman SG, Akbar SA, Mortele KJ, et al. (2006) Multi-detector row CT urography of normal urinary collecting system: furosemide versus saline as adjunct to contrast medium. Radiology 240(3):749–755CrossRefPubMed Silverman SG, Akbar SA, Mortele KJ, et al. (2006) Multi-detector row CT urography of normal urinary collecting system: furosemide versus saline as adjunct to contrast medium. Radiology 240(3):749–755CrossRefPubMed
15.
go back to reference Oliva MR, Glickman JN, Zou KH, et al. (2009) Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology. AJR 192(6):1524–1530CrossRefPubMed Oliva MR, Glickman JN, Zou KH, et al. (2009) Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology. AJR 192(6):1524–1530CrossRefPubMed
16.
go back to reference Shinagare AB, Vikram R, Jaffe C, et al. (2015) Radiogenomics of clear cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdom Imaging 40(6):1684–1692CrossRefPubMedPubMedCentral Shinagare AB, Vikram R, Jaffe C, et al. (2015) Radiogenomics of clear cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdom Imaging 40(6):1684–1692CrossRefPubMedPubMedCentral
17.
18.
go back to reference Silverman SG, Israel GM, Herts BR, Richie JP (2008) Management of the incidental renal mass. Radiology 249(1):16–31CrossRefPubMed Silverman SG, Israel GM, Herts BR, Richie JP (2008) Management of the incidental renal mass. Radiology 249(1):16–31CrossRefPubMed
19.
go back to reference Chung EP, Herts BR, Linnell G, et al. (2004) Analysis of changes in attenuation of proven renal cysts on different scanning phases of triphasic MDCT. AJR 182(2):405–410CrossRefPubMed Chung EP, Herts BR, Linnell G, et al. (2004) Analysis of changes in attenuation of proven renal cysts on different scanning phases of triphasic MDCT. AJR 182(2):405–410CrossRefPubMed
20.
go back to reference Rosenkrantz AB, Hindman N, Fitzgerald EF, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR 195:W421–W427CrossRefPubMed Rosenkrantz AB, Hindman N, Fitzgerald EF, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR 195:W421–W427CrossRefPubMed
21.
go back to reference Sun M, Abdollah F, Bianchi M, et al. (2012) Treatment management of small renal masses in the 21st century: a paradigm shift. Ann Surg Oncol 19(7):2380–2387CrossRefPubMed Sun M, Abdollah F, Bianchi M, et al. (2012) Treatment management of small renal masses in the 21st century: a paradigm shift. Ann Surg Oncol 19(7):2380–2387CrossRefPubMed
22.
go back to reference Lee-Felker SA, Felker ER, Tan N, et al. (2014) Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. AJR 203(5):W516–W524CrossRefPubMed Lee-Felker SA, Felker ER, Tan N, et al. (2014) Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. AJR 203(5):W516–W524CrossRefPubMed
23.
go back to reference Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267(2):444–453CrossRefPubMed Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267(2):444–453CrossRefPubMed
24.
go back to reference Williamson SR, Eble JN, Cheng L, Grignon DJ (2013) Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol. 26:697–708CrossRefPubMed Williamson SR, Eble JN, Cheng L, Grignon DJ (2013) Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol. 26:697–708CrossRefPubMed
25.
go back to reference Ruppert-Kohlmayr AJ, Uggowitzer M, Meissnitzer T, Ruppert G (2004) Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. AJR 183:1387–1391CrossRefPubMed Ruppert-Kohlmayr AJ, Uggowitzer M, Meissnitzer T, Ruppert G (2004) Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. AJR 183:1387–1391CrossRefPubMed
26.
go back to reference Zhang J, Lefkowitz RA, Ishill NM, et al. (2007) Solid renal cortical tumors: differentiation with CT. Radiology 244:494–504CrossRefPubMed Zhang J, Lefkowitz RA, Ishill NM, et al. (2007) Solid renal cortical tumors: differentiation with CT. Radiology 244:494–504CrossRefPubMed
27.
go back to reference Sun M, Ngo L, Genega EM, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes-correlation with pathologic findings. Radiology 250(3):793–802CrossRefPubMed Sun M, Ngo L, Genega EM, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes-correlation with pathologic findings. Radiology 250(3):793–802CrossRefPubMed
28.
go back to reference Bata P, Gyebnar J, Laszlo D, et al. (2013) Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT. Diagn interv Radiol 19:387–392PubMed Bata P, Gyebnar J, Laszlo D, et al. (2013) Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT. Diagn interv Radiol 19:387–392PubMed
Metadata
Title
Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes
Authors
Gevork N. Mnatzakanian
Atul B. Shinagare
V. Anik Sahni
Michelle S. Hirsch
Stuart G. Silverman
Publication date
01-11-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0830-8

Other articles of this Issue 11/2016

Abdominal Radiology 11/2016 Go to the issue

Classics in Abdominal Imaging

The “adnexal whirlpool” sign

Classics in Abdominal Imaging

The “accordion sign”

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine